Company Filing History:
Years Active: 1998-2012
Title: The Innovative Journey of Aaron W Schoeneman
Introduction
Aaron W Schoeneman, based in Lee's Summit, Missouri, is a notable inventor with a remarkable portfolio of five patents. His expertise in pharmaceutical compositions has significantly contributed to the medical field, particularly through his innovative approaches to drug formulations.
Latest Patents
Among Aaron's latest inventions is a pharmaceutical composition for piperidinoalkanol compounds. This invention provides a solid unit dosage form that includes a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof, along with at least one inert ingredient. This patent exemplifies Aaron's commitment to improving therapeutic options for patients, showcasing his innovative capabilities in the pharmaceutical industry.
Career Highlights
Aaron has garnered significant experience throughout his career, contributing his expertise to renowned companies such as Hoechst Marion Roussel and Aventis Pharmaceuticals Inc. His work at these companies has allowed him to refine his skills and deepen his understanding of pharmaceutical development, paving the way for his innovative contributions.
Collaborations
Throughout his journey, Aaron has collaborated with esteemed colleagues, including Thomas T Ortyl and Paul F Skultety. These collaborations have enabled him to push the boundaries of innovation in the pharmaceutical sector, resulting in significant advancements in drug formulations and healthcare solutions.
Conclusion
Aaron W Schoeneman's inventive spirit and dedication to advancing pharmaceutical compositions highlight his importance as an innovator in the industry. With five patents to his name and a strong background in prominent pharmaceutical companies, Aaron continues to contribute to the evolution of medical therapies through his inventive work. His journey serves as an inspiration to future inventors and a testament to the power of innovation in improving health outcomes.